UTDRO launches new CME course: Technological Innovations in Prostate Cancer Radiotherapy
The University of Toronto’s Department of Radiation Oncology (UTDRO) hosted a two-day continuing medical education (CME) course on prostate cancer radiotherapy on June 21 and 22, 2018. The first day of the course took place at the Ontario Power Generation Inc. building with afternoon workshops hosted in the Princess Margaret Hospital. The second day of the course took place at the Sunnybrook Odette Cancer Centre.
“Prostate cancer has significantly changed over the last two years and there is a lot of technology coming and treatment has been changing,” said Dr. Ewa Szumacher, Co-Director of Faculty Development and Continuing Education Professional Development at UTDRO. “This course highlights the modern innovation, not only in radiotherapy treatment and planning, but also in the enhanced collaboration and interprofessionalism in how we plan and treat patients.”
Dr. Rebecca Wong, Vice Chair of Education, on behalf of Dr. Fei Fei Liu, UTDRO Chair, welcomed the 34 registrants, 20 faculty members and seven sponsors to the event. She described the development of the course working closely with Dr. Ewa Szumacher, a Co-Director of the course.
“In creating the course, we wanted to develop a program that would bring excitement to the area of radiation medicine and at the same time take advantage of the depth of knowledge available through our six academic hospital centres that are partnered with UTDRO,” said Dr. Wong.
Dr. Szumacher and course Co-Director Dr. Catton worked with a planning committee to come up with the two full days of expert speakers and innovative content. The course was purposely designed to have a smaller number of participants allowing for an intimate, interactive environment with small group discussions, case studies and workshops.
Guest faculty included Dr. Robert Timmerman, Professor and Vice Chair of the Department of Radiation Oncology at the University of Texas, Southwestern Medical Center and Dr. Glenn Bauman, Chair of the Department of Oncology, Schulich School of Medicine and Dentistry, Western University. The remaining faculty members came from either Sunnybrook Odette Cancer Centre or Princess Margaret Hospital and the majority were affiliated with UTDRO.
This course would not have been possible without the generous support from our sponsors who we would like to thank: TerSera Canada, AbbVie Inc., Amgen Canada, Sanofi, Bayer, Ferring Pharmaceuticals, Astellas Oncology.
To learn more about the course, visit Technological Innovations in Prostate Cancer Radiotherapy. Read the course program here.